| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Fischer D | |
| Kolberg HC | |||
| Haase S | |||
| Stürzbecher HW | |||
| Hasselbach L | |||
| P433 | issue | 6 | |
| P304 | page(s) | 589-598 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | European Journal of Gynaecological Oncology | Q27710826 |
| P1476 | title | Characterisation of the promoter region of the human DNA-repair gene Rad51 | |
| P478 | volume | 26 |
| Q34103307 | Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells |
| Q45188292 | An increased risk of ovarian cancer associated with polymorphism in BRCC5 gene in Caucasian populations |
| Q40382294 | Association between RAD 51 rs1801320 and susceptibility to glioblastoma |
| Q35791593 | Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis |
| Q35980877 | Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women |
| Q33943829 | Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk |
| Q34293640 | Association of polymorphisms in the 5' untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population |
| Q33553786 | Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. |
| Q38238954 | DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance |
| Q34038587 | DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group |
| Q93040638 | FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways |
| Q43749889 | Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls |
| Q92312635 | Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis |
| Q93016470 | N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression |
| Q28267299 | Overexpression of RAD51 occurs in aggressive prostatic cancer |
| Q30922231 | Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability |
| Q35184378 | Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells |
| Q41133980 | Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population. |
| Q36261964 | Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population |
| Q36473585 | Polymorphisms in RAD51 and their relation with breast cancer in Saudi females. |
| Q54877659 | Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer. |
| Q35007346 | Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy |
| Q37259859 | Polymorphisms of the homologous recombination gene RAD51 in keratoconus and Fuchs endothelial corneal dystrophy |
| Q56986500 | Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy |
| Q36512097 | RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies |
| Q37562135 | RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis |
| Q37401616 | RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes |
| Q34008663 | RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer. |
| Q34425236 | RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines |
| Q34517369 | RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. |
| Q91600409 | Rab25-Mediated EGFR Recycling Causes Tumor Acquired Radioresistance |
| Q92438285 | Rad51 paralogs and the risk of unselected breast cancer: A case-control study |
| Q33952859 | Regulation of Rad51 promoter |
| Q37521105 | Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies |
| Q52684496 | STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. |
| Q35998714 | Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women |
| Q54186992 | The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer. |
| Q38399395 | The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis |
| Q47112944 | Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression |
| Q37081622 | Use of the Rad51 promoter for targeted anti-cancer therapy |
| Q28073944 | p53 in the DNA-Damage-Repair Process |
Search more.